期刊文献+

BNP在慢性心力衰竭诊断、治疗及预后中的应用价值 被引量:8

Application Value of BNP in Diagnosis, Treatment and Prognosis in Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的探讨血浆BNP水平在心力衰竭诊断、治疗以及预后中的应用价值。方法根据美国NYHA心功能分级标准选取我院90例慢性心力衰竭患者,测定不同心功能患者血浆中的BNP含量、左室舒张末期内径及左心室射血分数。结果血浆BNP水平与心功能的分级密切相关,血浆BNP水平与左室舒张末期内径呈正相关,与左心室射血分数呈负相关,差异有统计学意义(P<0.05)。结论血浆BNP水平能较好的反映心力衰竭患者的左室功能,是慢性心力衰竭诊断、治疗及预后的有效指标,在临床的应用上有重要意义。 Objective To discuss the application value of BNP in diagnosis, treatment and prognosis in patients with chronic heart failure (CHF) Methods 90 cases of CHF patients according to NYHA heart function classification in our hospital were selected, and their plasma BNP level, left ventricular end-diastolic diameter and left ventricular ejection fraction were examined. Results The plasma BNP level was closely related to heart function classification, positively correlated to left ventricular end-diastolic diameter, and negatively correlated with left ventricular ejection fraction, and the differences were statistically significant(P〈0.05). Conclusion Plasma BNP level can reflect left ventricular function in patients with heart failure, it's an effective indicator for diagnosis, treatment and prognosis of CHF, which is important in clinical application.
作者 吴振阳
出处 《中国医药指南》 2016年第15期13-14,共2页 Guide of China Medicine
关键词 慢性心力衰竭 血浆BNP水平 心功能不全 血浆标志物 Chronic heart failure Plasma BNP level Cardiac insufficiency Plasma marker
  • 相关文献

参考文献5

二级参考文献60

  • 1汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 2毛懿,杨跃进,张健,赵雪燕,倪新海,陈纪林,高润霖,陈在嘉.急性心肌梗死患者血B-型尿钠肽水平的变化特点[J].中华心血管病杂志,2006,34(5):425-428. 被引量:50
  • 3张春玲,康金锁,丛祥凤,于金星,张健,陈曦.冠心病患者血浆大内皮素水平与N末端脑钠肽及心功能关系的研究[J].中华检验医学杂志,2007,30(5):520-523. 被引量:13
  • 4田玮,付研,王勇.脑利钠肽与急性心肌梗死患者预后的临床探讨[J].北京医学,2007,29(6):352-355. 被引量:9
  • 5Sudoh T, Kangawa K, Minanino N, et al. A new natriuretic peptide in porcine brain[ J]. Nature, 1988,322:78 - 81.
  • 6Moura LM, Rocha Goncalves F, Zam orano JL, et al. New cardiovascu- lar biomarkers:clinical implications in patients with valvular heart dis- ease [ J ]. Expert Rev Cardiovasc Ther,2008,6 ( 7 ) :945.
  • 7Dwalne S, Burley Gary F, Baxter. B - type natriutetie peptide limits reperfusion injury via opening of ATP - sensetive potassium channels [J]. J Mol Cardiol,2006,40(6) :967 -968.
  • 8Mils RM, Lejemtel TH, Horton DP, et al. Sustaiined hem odynam ic effects of an infusion of nesiritide( human a - type natriuretic peptide) in heat failure [J]. J Am coil Cardiol, 1999,34:155 -162.
  • 9Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a na- triuretic peptide, in the treatent of decom pensated congestive heart failure[J]. N Engl J Med,2000,343:246.
  • 10Mair J, Lercher AH, Puschendort B. The impact of cardiac natriur Etic peptide determination on the diagnosis and management of heart fail- ure[J]. Clin Chem lab Med,2001,39(7) :571 -588.

共引文献92

同被引文献88

引证文献8

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部